Kamada Ltd.

Contributing Author

Recent Articles by Kamada Ltd.

Nov-10	Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth KMDA +5.41% GlobeNewswire
Nov-04	Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM to Prevent Cytomegalovirus in Kidney Transplantation KMDA GlobeNewswire
Nov-03	Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025 KMDA GlobeNewswire
Oct-29	Kamada to Present at the Stifel 2025 Healthcare Conference KMDA GlobeNewswire
Sep-02	Kamada to Participate in Upcoming September Investor Conferences KMDA GlobeNewswire
Aug-13	Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance KMDA GlobeNewswire
Aug-11	Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas KMDA GlobeNewswire
Aug-06	Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 KMDA GlobeNewswire
Jun-17	Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East KMDA GlobeNewswire
May-14	Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability KMDA GlobeNewswire
May-07	Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025 KMDA GlobeNewswire
May-05	Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM KMDA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.